Urolithiasis Management Devices Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy); By End-use; By Region, And Segment Forecasts, 2023 - 2032

Urolithiasis Management Devices Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy); By End-use; By Region, And Segment Forecasts, 2023 - 2032

The global urolithiasis management devices market size is expected to reach USD 3.51 billion by 2032, according to a new study by Polaris Market Research. The report “Urolithiasis Management Devices Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy), By End-use, By Region, And Segment Forecasts, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising incidence of urinary stones has driven advancements in treatment options. According to the European Association of Urology, it is a prevalent lifestyle disorder with a 10% prevalence rate, necessitating a systematic treatment approach. Urolithiasis refers to the formation of stones in the urinary system, including the kidneys, ureters, & bladder. It poses a significant healthcare concern in the U.S., Canada, & Germany, with a recurrence rate of nearly 50 percent in most of the cases.

While lifestyle changes, controlled diet, and basic medication can manage urolithiasis, various treatment approaches are required for the removal of large stones causing severe pain. Depending on the stone size, location, & anatomical variations, both invasive & non-invasive stone procedures are available.

Kidney stone disease is a prevalent urologic condition among adults in the U.S. Recent studies indicate that the prevalence of kidney stones has risen to approximately 1 in 10 individuals of all genders. Additionally, half of these individuals are likely to experience multiple symptomatic kidney stones throughout their lives. Inflammatory cells called macrophages influence the development of kidney stones from precursor materials. A recent study indicated that elevated calcium deposits in the kidney led to the activation of proinflammatory macrophages in patients who developed clinically significant stones, contrasting with the control group.

Intracorporeal lithotripsy treatments involve identifying and breaking down stones into smaller fragments using endoscopy. Techniques like ultrasound or laser are employed to disintegrate stones, allowing the passage of smaller pieces through the urinary system. Due to its high effectiveness in achieving a stone-free state, intracorporeal lithotripsy is expected to be a preferred treatment option in the forecast period. Additionally, percutaneous nephrolithotomy is a surgical method used for removing larger stones when extracorporeal or intracorporeal lithotripsies are ineffective, typically requiring a week-long hospital stay.

The introduction of advanced surgical technologies like endoscopy and micro accessories such as guidewires, scalpels, and baskets has significantly improved the acceptance of minimally invasive surgeries for efficiently removing stones from the urinary system within a short timeframe.

Urolithiasis Management Devices Market Report Highlights

In 2022, the intra-corporeal lithotripsy segment held the largest market share, as its high efficiency rate, and most suitable for renal stones in men

The intra-corporeal lithotripsy segment held the largest market share, on account for rising hospitals costs, and shortened hospital stays.

In 2022, North America region dominated the largest market share, rising cases of renal stones, surgical interventions, and awareness among consumer

The key market players include Cook Medical, ConMed, DirexGroup, Dornier MedTech, KARL STORZ, Olympus, Richard Wolf, and Siemens Healthcare.

Polaris Market Research has segmented the Urolithiasis management devices market report based on treatment type, end use, and region:

Urolithiasis Management Devices, Treatment Type Outlook (Revenue - USD Billion, 2023 - 2032)

Extracorporeal Shock Wave Lithotripsy (ESWL)

Intracorporeal Lithotripsy

Percutaneous Nephrolithotomy

Others

Urolithiasis Management Devices, End Use Outlook (Revenue - USD Billion, 2023 - 2032)

Hospitals & Clinics

Ambulatory Surgical Centers (ASCs)

Urolithiasis Management Devices, Regional Outlook (Revenue - USD Billion, 2023 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa